View of Incretin axis in cardiometabolic disease: molecular and systemic mechanisms of GLP-1 and GIP therapies

Return to Article Details Incretin axis in cardiometabolic disease: molecular and systemic mechanisms of GLP-1 and GIP therapies Download Download PDF